Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Vietnam in vitro diagnostics market was valued at USD 1.16 Billion in 2025, driven by increasing government healthcare investments and technological advancements across the region. The market is anticipated to grow at a CAGR of 5.50% during the forecast period of 2026-2035, with the values likely to reach USD 1.98 Billion by 2035. The increased chronic disease prevalence and government healthcare investments, and urbanization are likely to drive the demand for diagnostic solutions in Vietnam during the forecast period.
Base Year
Historical Period
Forecast Period
The Vietnam in vitro diagnostics market is driven by the increasing prevalence of chronic diseases, significant investments in healthcare infrastructure, and a rising demand for early and precise disease detection through advanced diagnostic technologies.
Key trends in the market include the growing adoption of molecular diagnostics, expansion of point-of-care testing solutions, and enhanced automation coupled with digital integration within diagnostic laboratories to improve efficiency and accuracy.
The market growth is further driven by the collaboration of local manufacturers, international in vitro diagnostics companies, and healthcare facilities, which enhance the availability of advanced diagnostic tests and foster continuous innovation.
Compound Annual Growth Rate
5.5%
Value in USD Billion
2026-2035
*this image is indicative*
In vitro diagnostics (IVD) encompass medical devices and laboratory tests conducted on samples, such as blood, urine, or tissue, collected from the human body to detect, diagnose, and monitor various diseases, conditions, or infections. IVD is essential for early disease detection, treatment management, and improving patient outcomes. The market is poised to grow at a CAGR of 5.50% during the forecast period of 2026-2035, due to growing healthcare awareness, increased government support, technological advancements, and the rising prevalence of chronic diseases.
Rising Prevalence of Non-Communicable Diseases to Elevate the Market Landscape
A significant factor driving the growth in the market is the increasing burden of non-communicable diseases (NCDs). According to the Department of Preventive Medicine, Ministry of Health, Vietnam recorded 727,000 deaths in 2019, with 81% attributed to NCDs. Nearly half of these deaths occurred before age 70, highlighting the urgent need for early diagnosis and monitoring. This rising disease burden is expected to accelerate market growth during the forecast period.
Some of the notable trends in the market include the growing implementation of health screening initiatives and the rising adoption of digital health solutions.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product & Services
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Immunodiagnostics Poised to Lead the Vietnam In Vitro Diagnostics Market
Different technologies are used in the in-vitro diagnostics market, which are into immunodiagnostics, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation and hemostasis, urinalysis, and additional segments. Among these, immunodiagnostics is expected to dominate the market, driven by its pivotal role in the timely and accurate diagnosis of infectious diseases, particularly tuberculosis (TB). Vietnam is among the top 30 high TB burden countries worldwide, with an incidence rate of approximately 176 cases per 100,000 individuals annually. These critical public health challenges are driving strong demand for advanced immunodiagnostic solutions, positioning this segment for significant growth.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
F. Hoffmann-La Roche Ltd., headquartered in Basel, Switzerland, was established in 1896 and is a global leader in in vitro diagnostics. Roche actively provides advanced diagnostic tests and instruments for diseases such as cancer, diabetes, COVID-19, and hepatitis. Its laboratory-based and point-of-care solutions enhance diagnostic accuracy and support timely clinical decisions, strengthening Vietnam’s diagnostic capabilities.
Established in 1952 and headquartered in Hercules, California, Bio-Rad Laboratories, Inc. actively contributes to the market through its advanced QXDx product line. These include the QXDx ddPCR System, AutoDG ddPCR System, and various universal and assay-specific kits designed for absolute quantification of nucleic acids. Their CE-IVD and FDA-cleared tools support regulated diagnostic workflows, especially in oncology.
Sysmex Corporation is a global leader in in vitro diagnostics. In June 2023, the company launched the HISCL β-Amyloid 1-42 and 1-40 Assay Kits, designed for early detection of Alzheimer’s disease through blood-based testing using the HISCL-Series. These innovative diagnostics offer minimally invasive, rapid analysis, aligning with growing demand in Vietnam for advanced, cost-effective testing solutions in neurological and immunochemistry diagnostics. Sysmex’s technological advancements contribute significantly to Vietnam’s evolving healthcare diagnostics landscape.
QIAGEN, headquartered in Hilden, Germany and established in 1984, is a global leader in molecular diagnostics. It partnered with Illumina Inc. to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) kits, including oncology-focused companion diagnostics. This collaboration enhances QIAGEN’s role in the in vitro diagnostics market by expanding access to advanced genomic testing for clinical decision-making.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Thermo Fisher Scientific Inc., and Abbott.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product & Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share